ORMP

Oramed Pharmaceuticals Inc. Press Releases

$4.46
*  
unch
unch
Get ORMP Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading ORMP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Oramed Closes $5 Million Investment From Guangxi Wuzhou Pharmaceutical Company
12/3/2014 8:25:00 AM - PR Newswire
▼-23.37 % Price Change since this news event. The Volume Ratio is 7.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Oramed Pharmaceuticals at LD MICRO "Main Event" Micro-Cap Growth Conference on December 2, 2014
12/1/2014 8:15:00 AM - PR Newswire
▼-25.67 % Price Change since this news event. The Volume Ratio is 1.92.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Coverage Initiation Report Focuses on Oramed Pharmaceuticals
11/11/2014 8:45:00 AM - Market Wire


Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes
10/31/2014 8:25:00 AM - PR Newswire
▼-39.73 % Price Change since this news event. The Volume Ratio is 4.94.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Oramed to Present at the FireRock Annual Micro-Cap Conference
10/24/2014 8:25:00 AM - PR Newswire


Oramed to Present at the FireRock Annual Micro-Cap Conference
10/24/2014 8:25:00 AM - PR Newswire
▼-43.04 % Price Change since this news event. The Volume Ratio is 1.18.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes
10/22/2014 8:29:00 AM - PR Newswire
▼-43.90 % Price Change since this news event. The Volume Ratio is 3.48.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day